Clinical trial

A Composite Assay for HER2-positive Early-stage Breast Cancer Management

NCT06762977

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2024-11-13

PhaseN/A

Study timeline

Study start (actual)2024-11-13Date precision: day

Registry last updated2025-01-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancer Early Stage Breast Cancer (Stage 1-3)unresolved

HER2unresolved

Interventions

Sponsors & collaborators

Fondazione IRCCS Istituto Nazionale dei Tumori, Milanolead sponsor

Istituto Nazionale Tumori IRCCS - Fondazione G. Pascalecollaborator

Ospedale Di Summa-Perrinocollaborator

Mapped research locations

NaplesItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06762977 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.